Table of Content

1. Key Insights

2. Executive Summary of Drug-Eluting Stents

3. Drug-Eluting Stents: Background and Overview
3.1. Introduction
3.2. Types of Drug-Eluting Stents
3.3. Advantages of Drug-Eluting Stents
3.4. Disadvantages of Drug-Eluting Stents

4. Drug-Eluting Stents: Regulatory Scenario

5. Drug-Eluting Stents: Reimbursement Scenario

6. Company Profiles
6.1. Abbott
6.1.1. Company Overview
6.1.2. Product Portfolio
6.1.2.1. Product description
6.1.2.2. Regulatory Milestones
6.1.2.3. Research and Development
6.1.2.4. Product Development Activities
6.2. B. Braun Melsungen AG
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.2.1. Product description
6.2.2.2. Regulatory Milestones
6.2.2.3. Research and Development
6.2.2.4. Product Development Activities
More Companies in the final report?

7. Drug-Eluting Stents: Competitive Analysis

8. KOL Views

9. Drug-Eluting Stents: Market Analysis in 7MM
9.1. Drug-Eluting Stents: Market Analysis in 7MM by Product type (2018–2026)
9.2. Drug-Eluting Stents: Market Analysis in 7MM by Scaffold (2018–2026)
9.3. Drug-Eluting Stents: Market Analysis in 7MM by End user (2018–2026)

10. Country-Wise Market size of Drug-Eluting Stents in 7MM (2018–2026)
10.1. Market size of Drug-Eluting Stents in the United States
10.1.1. Drug-Eluting Stents: Market Analysis in the United States by Product type (2018–2026)
10.1.2. Drug-Eluting Stents: Market Analysis in the United States by Scaffold (2018–2026)
10.1.3. Drug-Eluting Stents: Market Analysis in the United States by End user (2018–2026)
10.2. Market size of Drug-Eluting Stents in Germany
10.2.1. Drug-Eluting Stents: Market Analysis in Germany by Product type (2018–2026)
10.2.2. Drug-Eluting Stents: Market Analysis in Germany by Scaffold (2018–2026)
10.2.3. Drug-Eluting Stents: Market Analysis in Germany by End user (2018–2026)
10.3. Market size of Drug-Eluting Stents in France
10.3.1. Drug-Eluting Stents: Market Analysis in France by Product type (2018–2026)
10.3.2. Drug-Eluting Stents: Market Analysis in France by Scaffold (2018–2026)
10.3.3. Drug-Eluting Stents: Market Analysis in France by End user (2018–2026)
10.4. Market size of Drug-Eluting Stents in Spain
10.4.1. Drug-Eluting Stents: Market Analysis in Spain by Product type (2018–2026)
10.4.2. Drug-Eluting Stents: Market Analysis in Spain by Scaffold (2018–2026)
10.4.3. Drug-Eluting Stents: Market Analysis in Spain by End user (2018–2026)
10.5. Market size of Drug-Eluting Stents in Italy
10.5.1. Drug-Eluting Stents: Market Analysis in Italy by Product type (2018–2026)
10.5.2. Drug-Eluting Stents: Market Analysis in Italy by Scaffold (2018–2026)
10.5.3. Drug-Eluting Stents: Market Analysis in Italy by End user (2018–2026)
10.6. Market size of Drug-Eluting Stents in the UK
10.6.1. Drug-Eluting Stents: Market Analysis in the UK by Product type (2018–2026)
10.6.2. Drug-Eluting Stents: Market Analysis in the UK by Scaffold (2018–2026)
10.6.3. Drug-Eluting Stents: Market Analysis in the UK by End user (2018–2026)
10.7. Market size of Drug-Eluting Stents in Japan
10.7.1. Drug-Eluting Stents: Market Analysis in Japan by Product type (2018–2026)
10.7.2. Drug-Eluting Stents: Market Analysis in Japan by Scaffold (2018–2026)
10.7.3. Drug-Eluting Stents: Market Analysis in Japan by End user (2018–2026)

11. Market Dynamic
11.1. Market Drivers
11.2. Market Barriers

12. PEST Analysis

13. Conclusion and Future Perspective

14. Appendix
14.1. Bibliography
14.2. Report Methodology

15. DelveInsight Capabilities

16. Disclaimer

17. About DelveInsight



List of Figures


Figure 1: Product description of Drug-Eluting Stents
Figure 2: Drug-Eluting Stents: Market Analysis in the 7MM (2018–2026)
Figure 3: Drug-Eluting Stents: Market Analysis in the 7MM by Product type (2018–2026)
Figure 4: Drug-Eluting Stents: Market Analysis in the 7MM by Scaffold (2018–2026)
Figure 5: Drug-Eluting Stents: Market Analysis in the 7MM by End user (2018–2026)
Figure 6: Drug-Eluting Stents: United States Market Analysis (2018–2026)
Figure 7: Drug-Eluting Stents: Market Analysis in the US by Product type (2018-2026)
Figure 8: Drug-Eluting Stents: Market Analysis in the US by Scaffold (2018-2026)
Figure 9: Drug-Eluting Stents: Market Analysis in the US by End user (2018-2026)
Figure 10: Drug-Eluting Stents: Germany Market Analysis (2018–2026)
Figure 11: Drug-Eluting Stents: Market Analysis in Germany by Product type (2018-2026)
Figure 12: Drug-Eluting Stents: Market Analysis in Germany by Scaffold (2018-2026)
Figure 13: Drug-Eluting Stents: Market Analysis in Germany by End user (2018-2026)
Figure 14: Drug-Eluting Stents: France Market Analysis (2018–2026)
Figure 15: Drug-Eluting Stents: Market Analysis in France by Product type (2018-2026)
Figure 16: Drug-Eluting Stents: Market Analysis in France by Scaffold (2018-2026)
Figure 17: Drug-Eluting Stents: Market Analysis in France by End user (2018-2026)
Figure 18: Drug-Eluting Stents: Spain Market Analysis (2018–2026)
Figure 19: Drug-Eluting Stents: Market Analysis in Spain by Product type (2018-2026)
Figure 20: Drug-Eluting Stents: Market Analysis in Spain by Scaffold (2018-2026)
Figure 21: Drug-Eluting Stents: Market Analysis in Spain by End user (2018-2026)
Figure 22: Drug-Eluting Stents: Italy Market Analysis (2018–2026)
Figure 23: Drug-Eluting Stents: Market Analysis in Italy by Product type (2018-2026)
Figure 24: Drug-Eluting Stents: Market Analysis in Italy by Scaffold (2018-2026)
Figure 25: Drug-Eluting Stents: Market Analysis in Italy by End user (2018-2026)
Figure 26: Drug-Eluting Stents: United Kingdom Market Analysis (2018–2026)
Figure 27: Drug-Eluting Stents: Market Analysis in the UK by Product type (2018-2026)
Figure 28: Drug-Eluting Stents: Market Analysis in the UK by Scaffold (2018-2026)
Figure 29: Drug-Eluting Stents: Market Analysis in the UK by End user (2018-2026)
Figure 30: Drug-Eluting Stents: Japan Market Analysis (2018–2026)
Figure 31: Drug-Eluting Stents: Market Analysis in Japan by Product type (2018-2026)
Figure 32: Drug-Eluting Stents: Market Analysis in Japan by Scaffold (2018-2026)
Figure 33: Drug-Eluting Stents: Market Analysis in Japan by End user (2018-2026)
Figure 34: Market Drivers
Figure 35: Market Barriers


List of Tables


Table 1: Competitive Analysis
Table 2: Drug-Eluting Stents: Market Analysis in the 7MM (2018–2026)
Table 3: Drug-Eluting Stents: Market Analysis in the 7MM by Product type (2018–2026)
Table 4: Drug-Eluting Stents: Market Analysis in the 7MM by Scaffold (2018–2026)
Table 5: Drug-Eluting Stents: Market Analysis in the 7MM by End user (2018–2026)
Table 6: Drug-Eluting Stents: United States Market Analysis (2018–2026)
Table 7: Drug-Eluting Stents: Market Analysis in the US by Product type (2018-2026)
Table 8: Drug-Eluting Stents: Market Analysis in the US by Scaffold (2018-2026)
Table 9: Drug-Eluting Stents: Market Analysis in the US by End user (2018-2026)
Table 10: Drug-Eluting Stents: Germany Market Analysis (2018–2026)
Table 11: Drug-Eluting Stents: Market Analysis in Germany by Product type (2018-2026)
Table 12: Drug-Eluting Stents: Market Analysis in Germany by Scaffold (2018-2026)
Table 13: Drug-Eluting Stents: Market Analysis in Germany by End user (2018-2026)
Table 14: Drug-Eluting Stents: France Market Analysis (2018–2026)
Table 15: Drug-Eluting Stents: Market Analysis in France by Product type (2018-2026)
Table 16: Drug-Eluting Stents: Market Analysis in France by Scaffold (2018-2026)
Table 17: Drug-Eluting Stents: Market Analysis in France by End user (2018-2026)
Table 18: Drug-Eluting Stents: Spain Market Analysis (2018–2026)
Table 19: Drug-Eluting Stents: Market Analysis in Spain by Product type (2018-2026)
Table 20: Drug-Eluting Stents: Market Analysis in Spain by Scaffold (2018-2026)
Table 21: Drug-Eluting Stents: Market Analysis in Spain by End user (2018-2026)
Table 22: Drug-Eluting Stents: Italy Market Analysis (2018–2026)
Table 23: Drug-Eluting Stents: Market Analysis in Italy by Product type (2018-2026)
Table 24: Drug-Eluting Stents: Market Analysis in Italy by Scaffold (2018-2026)
Table 25: Drug-Eluting Stents: Market Analysis in Italy by End user (2018-2026)
Table 26: Drug-Eluting Stents: United Kingdom Market Analysis (2018–2026)
Table 27: Drug-Eluting Stents: Market Analysis in the UK by Product type (2018-2026)
Table 28: Drug-Eluting Stents: Market Analysis in the UK by Scaffold (2018-2026)
Table 29: Drug-Eluting Stents: Market Analysis in the UK by End user (2018-2026)
Table 30: Drug-Eluting Stents: Japan Market Analysis (2018–2026)
Table 31: Drug-Eluting Stents: Market Analysis in Japan by Product type (2018-2026)
Table 32: Drug-Eluting Stents: Market Analysis in Japan by Scaffold (2018-2026)
Table 33: Drug-Eluting Stents: Market Analysis in Japan by End user (2018-2026)